Literature DB >> 28723897

Cancer: A precision approach to tumour treatment.

Rodrigo Dienstmann1, Josep Tabernero2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28723897     DOI: 10.1038/nature23101

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Authors:  Chantal Pauli; Benjamin D Hopkins; Davide Prandi; Reid Shaw; Tarcisio Fedrizzi; Andrea Sboner; Verena Sailer; Michael Augello; Loredana Puca; Rachele Rosati; Terra J McNary; Yelena Churakova; Cynthia Cheung; Joanna Triscott; David Pisapia; Rema Rao; Juan Miguel Mosquera; Brian Robinson; Bishoy M Faltas; Brooke E Emerling; Vijayakrishna K Gadi; Brady Bernard; Olivier Elemento; Himisha Beltran; Francesca Demichelis; Christopher J Kemp; Carla Grandori; Lewis C Cantley; Mark A Rubin
Journal:  Cancer Discov       Date:  2017-03-22       Impact factor: 39.397

2.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.

Authors:  Miguel Crespo; Eduardo Vilar; Su-Yi Tsai; Kyle Chang; Sadaf Amin; Tara Srinivasan; Tuo Zhang; Nina H Pipalia; Huanhuan Joyce Chen; Mavee Witherspoon; Miriam Gordillo; Jenny Zhaoying Xiang; Frederick R Maxfield; Steven Lipkin; Todd Evans; Shuibing Chen
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

3.  Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Authors:  Tea Pemovska; Mika Kontro; Bhagwan Yadav; Henrik Edgren; Samuli Eldfors; Agnieszka Szwajda; Henrikki Almusa; Maxim M Bespalov; Pekka Ellonen; Erkki Elonen; Bjørn T Gjertsen; Riikka Karjalainen; Evgeny Kulesskiy; Sonja Lagström; Anna Lehto; Maija Lepistö; Tuija Lundán; Muntasir Mamun Majumder; Jesus M Lopez Marti; Pirkko Mattila; Astrid Murumägi; Satu Mustjoki; Aino Palva; Alun Parsons; Tero Pirttinen; Maria E Rämet; Minna Suvela; Laura Turunen; Imre Västrik; Maija Wolf; Jonathan Knowles; Tero Aittokallio; Caroline A Heckman; Kimmo Porkka; Olli Kallioniemi; Krister Wennerberg
Journal:  Cancer Discov       Date:  2013-09-20       Impact factor: 39.397

4.  High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Authors:  Christophe Massard; Stefan Michiels; Charles Ferté; Marie-Cécile Le Deley; Ludovic Lacroix; Antoine Hollebecque; Loic Verlingue; Ecaterina Ileana; Silvia Rosellini; Samy Ammari; Maud Ngo-Camus; Rastislav Bahleda; Anas Gazzah; Andrea Varga; Sophie Postel-Vinay; Yohann Loriot; Caroline Even; Ingrid Breuskin; Nathalie Auger; Bastien Job; Thierry De Baere; Frederic Deschamps; Philippe Vielh; Jean-Yves Scoazec; Vladimir Lazar; Catherine Richon; Vincent Ribrag; Eric Deutsch; Eric Angevin; Gilles Vassal; Alexander Eggermont; Fabrice André; Jean-Charles Soria
Journal:  Cancer Discov       Date:  2017-04-01       Impact factor: 39.397

5.  Prospective derivation of a living organoid biobank of colorectal cancer patients.

Authors:  Marc van de Wetering; Hayley E Francies; Joshua M Francis; Gergana Bounova; Francesco Iorio; Apollo Pronk; Winan van Houdt; Joost van Gorp; Amaro Taylor-Weiner; Lennart Kester; Anne McLaren-Douglas; Joyce Blokker; Sridevi Jaksani; Sina Bartfeld; Richard Volckman; Peter van Sluis; Vivian S W Li; Sara Seepo; Chandra Sekhar Pedamallu; Kristian Cibulskis; Scott L Carter; Aaron McKenna; Michael S Lawrence; Lee Lichtenstein; Chip Stewart; Jan Koster; Rogier Versteeg; Alexander van Oudenaarden; Julio Saez-Rodriguez; Robert G J Vries; Gad Getz; Lodewyk Wessels; Michael R Stratton; Ultan McDermott; Matthew Meyerson; Mathew J Garnett; Hans Clevers
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

6.  Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Authors:  Moritz Schütte; Thomas Risch; Nilofar Abdavi-Azar; Karsten Boehnke; Dirk Schumacher; Marlen Keil; Reha Yildiriman; Christine Jandrasits; Tatiana Borodina; Vyacheslav Amstislavskiy; Catherine L Worth; Caroline Schweiger; Sandra Liebs; Martin Lange; Hans-Jörg Warnatz; Lee M Butcher; James E Barrett; Marc Sultan; Christoph Wierling; Nicole Golob-Schwarzl; Sigurd Lax; Stefan Uranitsch; Michael Becker; Yvonne Welte; Joseph Lewis Regan; Maxine Silvestrov; Inge Kehler; Alberto Fusi; Thomas Kessler; Ralf Herwig; Ulf Landegren; Dirk Wienke; Mats Nilsson; Juan A Velasco; Pilar Garin-Chesa; Christoph Reinhard; Stephan Beck; Reinhold Schäfer; Christian R A Regenbrecht; David Henderson; Bodo Lange; Johannes Haybaeck; Ulrich Keilholz; Jens Hoffmann; Hans Lehrach; Marie-Laure Yaspo
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

  6 in total
  5 in total

1.  CORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Authors:  Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2018-07       Impact factor: 4.176

Review 2.  The failure of rodent carcinogenesis as a model for Man.

Authors:  Colin Berry
Journal:  Toxicol Res (Camb)       Date:  2017-12-20       Impact factor: 3.524

Review 3.  Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?

Authors:  David Gómez-Peregrina; Alfonso García-Valverde; Daniel Pilco-Janeta; César Serrano
Journal:  Curr Treat Options Oncol       Date:  2021-02-27

4.  Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System.

Authors:  Qiang Li; Haishuang Lin; Jack Rauch; Loic P Deleyrolle; Brent A Reynolds; Hendrik J Viljoen; Chi Zhang; Chi Zhang; Linxia Gu; Erika Van Wyk; Yuguo Lei
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

5.  Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.

Authors:  Markus Germann; Nadine Zangger; Marc-Olivier Sauvain; Christine Sempoux; Amber D Bowler; Pratyaksha Wirapati; Lana E Kandalaft; Mauro Delorenzi; Sabine Tejpar; George Coukos; Freddy Radtke
Journal:  EMBO Mol Med       Date:  2019-12-02       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.